MVP and neoplasm: In particular, to deliver greater amounts of DNA to the nucleus in multidrug-resistant tumor cells using PAMAM-NH2, we suggest the codelivery of siRNA-MVP or an inhibitor to decrease the nuclear efflux generated by MVP.